Mucociliary Clearance Techniques for Acute Bronchiolitis
CLEARBRONCH
Efficacy of Mucociliary Clearance Techniques in Non-hospitalised Infants with Acute Bronchiolitis
2 other identifiers
interventional
70
0 countries
N/A
Brief Summary
To assess the efficacy of mucociliary clearance techniques in non-hospitalised infants with a first episode of mild to moderate acute bronchiolitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2024
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 13, 2024
CompletedFirst Posted
Study publicly available on registry
November 14, 2024
CompletedStudy Start
First participant enrolled
December 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2025
CompletedNovember 19, 2024
November 1, 2024
6 months
November 13, 2024
November 14, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
ESBA
The variables collected using the ESBA scale were: wheezing, crackles, inspiratory effort, Inspiratory/Expiratory ratio, respiratory rate and heart rate.
1 session (45 minutes)
Study Arms (1)
Treatment group
EXPERIMENTALThe intervention consisted of a Respiratory Physiotherapy session including: mucociliary clearance techniques (prolonged slow expiration and provoked cough), bronchodilator when prescribed and nebulisation with 3% hypertonic saline.
Interventions
Mucociliary clearance techniques (prolonged slow expiration and provoked cough), bronchodilator when prescribed and nebulisation with 3% hypertonic saline.
Eligibility Criteria
You may qualify if:
- Medical diagnosis of first episode of acute Bronchiolitis.
- Acute Bronchiolitis with mild (ESBA score = 1-4) or moderate (ESBA score =5-9) severity according to the ESBA.
- Informed consent signed by parents or legal guardians.
You may not qualify if:
- Infants previously diagnosed with chronic respiratory disease.
- Previous episodes of wheezing.
- Presence of any type of contraindication to receive Respiratory Physiotherapy treatment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Gonzalez Bellido V, Velaz Baza V, Esteo MDCJ, Carballo RG, Colombo A, Zaldivar JNC, Donadio MVF. Safety of airway clearance combined with bronchodilator and hypertonic saline in non-hospitalized infants with acute bronchiolitis. Arch Pediatr. 2021 Nov;28(8):707-711. doi: 10.1016/j.arcped.2021.09.007. Epub 2021 Oct 5.
PMID: 34625378BACKGROUND
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator and Associate Professor
Study Record Dates
First Submitted
November 13, 2024
First Posted
November 14, 2024
Study Start
December 1, 2024
Primary Completion
May 31, 2025
Study Completion
May 31, 2025
Last Updated
November 19, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share